Inhibition of CREB function in mouse epidermis reduces papilloma formation

Julian Rozenberg, Vikas Rishi, Andras Orosz, Jaideep Moitra, Adam Glick, Charles Vinson

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

We used a double transgenic tetracycline system to conditionally express A-CREB, a dominant negative protein that prevents the DNA binding and function of cAMP-responsive element binding protein (CREB) family members, in mouse basal epidermis using the keratin 5 promoter. There was no phenotype in the adult. However, following a 7,12-dimethylbenz(a)anthracene (DMBA)/phorbol-12-myristate- 13-acetate two-stage skin carcinogenesis experiment, A-CREB - expressing epidermis develop 5-fold fewer papillomas than wild-type controls. However, A-CREB expression one month after DMBA treatment does not prevent papilloma formation, suggesting that CREB functions at an early stage of papilloma formation. Oncogenic H-Ras genes with A→T mutations in codon 61 were found in wild-type skin but not in A-CREB - expressing skin 2 days after DMBA treatment, suggesting that A-CREB either prevents DMBA mutagenesis or kills oncogenic H-Ras cells. In primary keratinocyte cultures, A-CREB expression induced apoptosis of v-RasHa-infected cells and suppressed the expression of cell cycle proteins cyclin B1 and cyclin D1. These results suggest that inhibiting CREB function is a valuable cancer prevention strategy.

Original languageEnglish (US)
Pages (from-to)654-664
Number of pages11
JournalMolecular Cancer Research
Volume7
Issue number5
DOIs
StatePublished - May 1 2009

Fingerprint

Papilloma
Epidermis
Carrier Proteins
9,10-Dimethyl-1,2-benzanthracene
Skin
Keratin-5
Cyclin B1
Inhibition (Psychology)
Cell Cycle Proteins
ras Genes
Cyclin D1
DNA-Binding Proteins
Tetracycline
Keratinocytes
Codon
Mutagenesis
Carcinogenesis
Acetates
Apoptosis
Phenotype

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Oncology
  • Cancer Research

Cite this

Rozenberg, Julian ; Rishi, Vikas ; Orosz, Andras ; Moitra, Jaideep ; Glick, Adam ; Vinson, Charles. / Inhibition of CREB function in mouse epidermis reduces papilloma formation. In: Molecular Cancer Research. 2009 ; Vol. 7, No. 5. pp. 654-664.
@article{720bc4573f7f44ef916c53c11104dd34,
title = "Inhibition of CREB function in mouse epidermis reduces papilloma formation",
abstract = "We used a double transgenic tetracycline system to conditionally express A-CREB, a dominant negative protein that prevents the DNA binding and function of cAMP-responsive element binding protein (CREB) family members, in mouse basal epidermis using the keratin 5 promoter. There was no phenotype in the adult. However, following a 7,12-dimethylbenz(a)anthracene (DMBA)/phorbol-12-myristate- 13-acetate two-stage skin carcinogenesis experiment, A-CREB - expressing epidermis develop 5-fold fewer papillomas than wild-type controls. However, A-CREB expression one month after DMBA treatment does not prevent papilloma formation, suggesting that CREB functions at an early stage of papilloma formation. Oncogenic H-Ras genes with A→T mutations in codon 61 were found in wild-type skin but not in A-CREB - expressing skin 2 days after DMBA treatment, suggesting that A-CREB either prevents DMBA mutagenesis or kills oncogenic H-Ras cells. In primary keratinocyte cultures, A-CREB expression induced apoptosis of v-RasHa-infected cells and suppressed the expression of cell cycle proteins cyclin B1 and cyclin D1. These results suggest that inhibiting CREB function is a valuable cancer prevention strategy.",
author = "Julian Rozenberg and Vikas Rishi and Andras Orosz and Jaideep Moitra and Adam Glick and Charles Vinson",
year = "2009",
month = "5",
day = "1",
doi = "10.1158/1541-7786.MCR-08-0011",
language = "English (US)",
volume = "7",
pages = "654--664",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

Inhibition of CREB function in mouse epidermis reduces papilloma formation. / Rozenberg, Julian; Rishi, Vikas; Orosz, Andras; Moitra, Jaideep; Glick, Adam; Vinson, Charles.

In: Molecular Cancer Research, Vol. 7, No. 5, 01.05.2009, p. 654-664.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inhibition of CREB function in mouse epidermis reduces papilloma formation

AU - Rozenberg, Julian

AU - Rishi, Vikas

AU - Orosz, Andras

AU - Moitra, Jaideep

AU - Glick, Adam

AU - Vinson, Charles

PY - 2009/5/1

Y1 - 2009/5/1

N2 - We used a double transgenic tetracycline system to conditionally express A-CREB, a dominant negative protein that prevents the DNA binding and function of cAMP-responsive element binding protein (CREB) family members, in mouse basal epidermis using the keratin 5 promoter. There was no phenotype in the adult. However, following a 7,12-dimethylbenz(a)anthracene (DMBA)/phorbol-12-myristate- 13-acetate two-stage skin carcinogenesis experiment, A-CREB - expressing epidermis develop 5-fold fewer papillomas than wild-type controls. However, A-CREB expression one month after DMBA treatment does not prevent papilloma formation, suggesting that CREB functions at an early stage of papilloma formation. Oncogenic H-Ras genes with A→T mutations in codon 61 were found in wild-type skin but not in A-CREB - expressing skin 2 days after DMBA treatment, suggesting that A-CREB either prevents DMBA mutagenesis or kills oncogenic H-Ras cells. In primary keratinocyte cultures, A-CREB expression induced apoptosis of v-RasHa-infected cells and suppressed the expression of cell cycle proteins cyclin B1 and cyclin D1. These results suggest that inhibiting CREB function is a valuable cancer prevention strategy.

AB - We used a double transgenic tetracycline system to conditionally express A-CREB, a dominant negative protein that prevents the DNA binding and function of cAMP-responsive element binding protein (CREB) family members, in mouse basal epidermis using the keratin 5 promoter. There was no phenotype in the adult. However, following a 7,12-dimethylbenz(a)anthracene (DMBA)/phorbol-12-myristate- 13-acetate two-stage skin carcinogenesis experiment, A-CREB - expressing epidermis develop 5-fold fewer papillomas than wild-type controls. However, A-CREB expression one month after DMBA treatment does not prevent papilloma formation, suggesting that CREB functions at an early stage of papilloma formation. Oncogenic H-Ras genes with A→T mutations in codon 61 were found in wild-type skin but not in A-CREB - expressing skin 2 days after DMBA treatment, suggesting that A-CREB either prevents DMBA mutagenesis or kills oncogenic H-Ras cells. In primary keratinocyte cultures, A-CREB expression induced apoptosis of v-RasHa-infected cells and suppressed the expression of cell cycle proteins cyclin B1 and cyclin D1. These results suggest that inhibiting CREB function is a valuable cancer prevention strategy.

UR - http://www.scopus.com/inward/record.url?scp=66349111223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66349111223&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-08-0011

DO - 10.1158/1541-7786.MCR-08-0011

M3 - Article

C2 - 19435810

AN - SCOPUS:66349111223

VL - 7

SP - 654

EP - 664

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 5

ER -